Imidin (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride works by stimulating alpha‑adrenergic receptors on the blood vessels of the nasal mucosa. This causes vasoconstriction, which reduces swelling and excess fluid, opening the airway and decreasing the feeling of congestion.

The exact dose of Imidin is determined by the prescribing healthcare professional. Typical dosing instructions for adults and children over a certain age involve one or two sprays per nostril, not exceeding three days of continuous use, but the prescriber sets the final regimen.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Imidin.

To order Imidin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imidin (Xylometazoline) and other imidazoline or phenylephrine‑based nasal sprays share a similar mechanism of vasoconstriction. Compared with oxymetazoline, Xylometazoline has a comparable onset of action but may have a slightly shorter duration, requiring similar dosing limits to avoid rebound congestion.

Imidin should be stored at room temperature, below 25 °C, in its original packaging. Protect the spray from moisture, excessive heat, and direct sunlight. Keep the container tightly closed when not in use to maintain product stability.

Imidin is administered as a nasal spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

The most serious risks include rebound nasal congestion (rhinitis medicamentosa) if used longer than recommended, and systemic effects such as elevated blood pressure or cardiac arrhythmias, particularly in patients with pre‑existing cardiovascular conditions.

Imidin should not be used by individuals with known hypersensitivity to Xylometazoline or any excipients, children under two years of age unless advised by a physician, and patients with severe hypertension, coronary artery disease, or recent nasal surgery without medical clearance.